Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer

• Hauptverfasser: Yuan Li (Verfasst von), Caiming Xu (Verfasst von), Haiyong Han (Verfasst von), Silvia Pascual-Sabater (Verfasst von), Cristina Fillat (Verfasst von), Ajay Goel (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2024-07-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor survival rates, primarily due to the limited effectiveness of gemcitabine (Gem)-based chemotherapy, as well as the acquisition of chemotherapeutic resistance. Aronia berry extracts (ABEs), abundant in phenolic constituents,...